rs267608687
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP2PP5
The NM_018082.6(POLR3B):c.2303G>A(p.Arg768His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000632 in 1,612,764 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018082.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLR3B | NM_018082.6 | c.2303G>A | p.Arg768His | missense_variant | Exon 21 of 28 | ENST00000228347.9 | NP_060552.4 | |
POLR3B | NM_001160708.2 | c.2129G>A | p.Arg710His | missense_variant | Exon 21 of 28 | NP_001154180.1 | ||
POLR3B | XM_017019621.3 | c.2303G>A | p.Arg768His | missense_variant | Exon 21 of 26 | XP_016875110.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLR3B | ENST00000228347.9 | c.2303G>A | p.Arg768His | missense_variant | Exon 21 of 28 | 1 | NM_018082.6 | ENSP00000228347.4 | ||
POLR3B | ENST00000539066.5 | c.2129G>A | p.Arg710His | missense_variant | Exon 21 of 28 | 2 | ENSP00000445721.1 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 152034Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000836 AC: 21AN: 251166Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135746
GnomAD4 exome AF: 0.0000623 AC: 91AN: 1460612Hom.: 0 Cov.: 30 AF XY: 0.0000674 AC XY: 49AN XY: 726684
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74366
ClinVar
Submissions by phenotype
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism Pathogenic:2Uncertain:1Other:1
- -
- -
Based on the classification scheme VCGS_Germline_v1.3.5, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (MIM#614381). Dominant negative is a suspected mechanism of disease for this gene and is associated with Charcot-Marie-Tooth disease, demyelinating, type 1I (MIM#619742) (PMID: 33417887). (I) 0108 - This gene is associated with both recessive and dominant disease. Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism has biallelic inheritance and Charcot-Marie-Tooth disease, demyelinating, type 1I has monoallelic inheritance (OMIM). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to histidine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v4; 102 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v4; 29 heterozygotes, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and very high conservation. (I) 0600 - Variant is located in the annotated RNA polymerase Rpb2, domain 6 (DECIPHER). (I) 0703 - Another missense variant comparable to the one identified in this case has moderate previous evidence for pathogenicity. An alternative change, p.(Arg768Cys), has been classified as likely pathogenic and VUS by clinical laboratories in ClinVar and has been reported in homozygous and compound heterozygous individuals with POLR3B-related features (PMIDs: 27029625, 32371413). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as likely pathogenic/pathogenic multiple times and once as a VUS by clinical laboratories in ClinVar. It has also been identified in compound heterozygous and homozygous individuals with leukodystrophy (PMIDs: 22036171, 32180488). (SP) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
The p.Arg768His variant in POLR3B has been reported in 3 individuals with 4H leukodystrophy (PMID: 22036171, 26597493, 32180488), and has been identified in 0.06% (18/30612) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs267608687). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. Of the 3 affected individuals, 1 of those was a homozygote and 1 was a compound heterozygote that carried a variant of uncertain significance in trans, which increases the likelihood that the p.Arg768His variant is pathogenic (VariationID: 31160; PMID: 22036171, 32180488). This variant has also been reported in ClinVar (Variation ID#: 31161) and has been interpreted as a VUS by GeneDx and pathogenic by GeneReviews and OMIM. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The number of missense variants reported in POLR3B in the general population is lower than expected, suggesting there is little benign variation in this gene and slightly increasing the possibility that a missense variant in this gene may not be tolerated. In summary, the clinical significance of the p.Arg768His variant is uncertain. ACMG/AMP Criteria applied: PP3, PP2, PM3_supporting (Richards 2015). -
not provided Pathogenic:2Uncertain:1
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22855961, 26597493, 32180488, 22036171, 31589614) -
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 768 of the POLR3B protein (p.Arg768His). This variant is present in population databases (rs267608687, gnomAD 0.06%). This missense change has been observed in individual(s) with clinical features of autosomal recessive hypomyelinating leukodystrophy (PMID: 22036171, 32180488; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 31161). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt POLR3B protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
POLR-related leukodystrophy Pathogenic:1
Variant summary: POLR3B c.2303G>A (p.Arg768His) results in a non-conservative amino acid change located in the DNA-directed RNA polymerase, subunit 2, hybrid-binding domain (IPR007120) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8.4e-05 in 251166 control chromosomes, predominantly at a frequency of 0.00059 within the South Asian subpopulation in the gnomAD database. c.2303G>A has been reported in the literature in the homozygous and compound heterozygous state in individuals affected with POLR3-Related Leukodystrophy (e.g. Saitsu_2011, Parayil Sankaran_2020). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. One laboratory classified the variant as pathogenic, and one laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
POLR3B-related disorder Pathogenic:1
The POLR3B c.2303G>A variant is predicted to result in the amino acid substitution p.Arg768His. This variant has been reported in the homozygous and compound heterozygous state in individuals with hypomyelinating leukodystrophy (Saitsu et al 2011. PubMed ID: 22036171; Parayil Sankaran et al. 2020. PubMed ID: 32180488). This variant is reported in 0.059% of alleles in individuals of South Asian descent in gnomAD. This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at